Trial · NCT03307252
Results by group88
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 88
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Verapamil + R1 (T1) | Digoxin | 13.71 | Standard Error 1.10 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Cocktail (R1) | Digoxin | 13.61 | Standard Error 1.10 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Verapamil + R1 (T1) | Furosemide | 165.80 | Standard Error 1.06 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Cocktail (R1) | Furosemide | 176.85 | Standard Error 1.06 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Verapamil + R1 (T1) | Metformin | 1126.22 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Cocktail (R1) | Metformin | 1357.34 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Verapamil + R1 (T1) | Rosuvastatin | 98.98 | Standard Error 1.11 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Verapamil + R1 (T1) vs. R1) | Cocktail (R1) | Rosuvastatin | 87.29 | Standard Error 1.11 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Rifampin + R1 (T2) | Digoxin | 17.89 | Standard Error 1.10 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Cocktail (R1) | Digoxin | 13.61 | Standard Error 1.10 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Rifampin + R1 (T2) | Furosemide | 211.82 | Standard Error 1.06 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Cocktail (R1) | Furosemide | 176.85 | Standard Error 1.06 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Rifampin + R1 (T2) | Metformin | 1473.38 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Cocktail (R1) | Metformin | 1357.34 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Rifampin + R1 (T2) | Rosuvastatin | 303.81 | Standard Error 1.11 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Rifampin + R1 (T2) vs. R1) | Cocktail (R1) | Rosuvastatin | 87.29 | Standard Error 1.11 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Cimetidine + R1 (T3) vs. R1) | Cimetidine + R1 (T3) | Digoxin | 19.03 | Standard Error 1.07 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Cimetidine + R1 (T3) vs. R1) | Cocktail (R1) | Digoxin | 15.15 | Standard Error 1.07 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Cimetidine + R1 (T3) vs. R1) | Cimetidine + R1 (T3) | Furosemide | 196.39 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
| Area Under the Concentration-time Curve of the Analyte in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) (Cimetidine + R1 (T3) vs. R1) | Cocktail (R1) | Furosemide | 194.05 | Standard Error 1.05 | Nanomole*hour/litre (nmol*h/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03307252/results